The Latest in Psoriasis

Dermatology News

Dermatologists fear effects of Dobbs decision for patients on isotretinoin, methotrexate

October 14, 2022

Dermatology News

A White female presented with pustules and erythematous macules on the left palm

October 14, 2022

Medicare Part D Prescription Claims for Brodalumab: Analysis of Annual Trends for 2017-2019

October 5, 2022

Psoriasis

Dermatology News

Apremilast may have some cardiometabolic benefits in patients with psoriasis

September 27, 2022

Dermatology News

Psoriasis, psoriatic arthritis insurance coverage remains restrictive

September 26, 2022

Dermatology News

Apremilast alleviates severe psoriasis in some children, data show

September 20, 2022

Open Clinical Trials for Psoriasis

September 19, 2022

Psoriasis

Dermatology News

Brodalumab suicide risk similar to other biologics, postmarket study finds

September 19, 2022

Dermatology News

Artemisia capillaris extract

September 16, 2022

Dermatology News

Sustained response at 2 years reported for newly approved oral psoriasis agent

September 15, 2022

Optimizing Narrowband UVB Phototherapy: Is It More Challenging for Your Older Patients?

September 14, 2022

Dermatology News

FDA approves oral TYK2 inhibitor deucravacitinib for treating psoriasis

September 12, 2022

Surgical Deroofing for Hidradenitis Suppurativa

September 12, 2022

Dermatology News

Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?

September 8, 2022

Dermatology News

FDA okays spesolimab, first treatment for generalized pustular psoriasis

September 2, 2022